Richard T. Silver, MD

home / authors / richard-t-silver-md

Articles

Jorge E. Cortes, MD;Richard T. Silver, MD;H. Jean Khoury, MD;Hagop M. Kantarjian, MD

June 1st 2016

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder resulting from the neoplastic transformation of the primitive hematopoietic stem cell.

Cancer Management Chapter 30: Chronic myeloid leukemia

Jorge E. Cortes, MD;Richard T. Silver, MD;Hagop M. Kantarjian, MD

March 15th 2010

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder resulting from the neoplastic transformation of the primitive hematopoietic stem cell. The disease is monoclonal in origin, affecting myeloid, monocytic, erythroid, megakaryocytic, B-cell, and, sometimes, T-cell lineages. Bone marrow stromal cells are not involved.

Chronic Myelogenous Leukemia

Jorge E. Cortes, MD;Richard T. Silver, MD;Hagop M. Kantarjian, MD

June 1st 2007

Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder resulting from the neoplastic transformation of the primitive hematopoietic stem cell. The disease is monoclonal in origin, affecting myeloid, monocytic, erythroid, megakaryocytic, B-cell, and, sometimes, T-cell lineages. Bone marrow stromal cells are not involved.

Chronic myelogenous leukemia

Jorge E. Cortes, MD;Richard T. Silver, MD;Hagop M. Kantarjian, MD

January 1st 2005

Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorderresulting from the neoplastic transformation of the primitive hematopoietic stemcell. The disease is monoclonal in origin, affecting myeloid, monocytic, erythroid,megakaryocytic, B-cell, and, sometimes, T-cell lineages. Bone marrowstromal cells are not involved.